Wdr19 Antibody

What is WDR19 and what cellular functions does it perform?

WDR19, also known as WD repeat-containing protein 19 or IFT144, is a component of the intraflagellar transport system that plays an essential mechanical role in retrograde ciliary transport. As part of the IFT complex A (IFT-A), it's involved in cilia function and assembly, and is essential for functional IFT-A assembly and ciliary entry of G protein-coupled receptors (GPCRs) . The protein associates with the BBSome complex to mediate ciliary transport and contains multiple structural domains including six WD40 repeats, three TPR repeats, one COG5290, and one double zinc ribbon (DZR) domain . Sequence analysis reveals that the WDR19 gene is conserved from Caenorhabditis elegans to humans, underscoring its evolutionary importance .

What types of WDR19 antibodies are available for research applications?

Several types of WDR19 antibodies are available for research purposes:

• Rabbit Polyclonal WDR19 antibodies (such as ab105044) suitable for Western Blot applications with reactivity against human and mouse samples

• Rabbit Recombinant Monoclonal WDR19 antibody (such as EPR24915-11/ab270970) suitable for Immunoprecipitation (IP) and Western Blot (WB) applications with reactivity against mouse, human, and rat samples

• Other polyclonal antibodies like 13647-1-AP (proteintech) that have been validated for immunofluorescence applications

The choice of antibody depends on the specific application, species of interest, and experimental conditions required.

How is WDR19 localized in normal cells and how can this be visualized using antibodies?

In normal cells, WDR19 is typically localized to specific cellular structures involved in ciliary function. Immunofluorescence staining of healthy control sperm reveals that WDR19 is highly expressed in the sperm neck and flagella in a punctate pattern along the axoneme . This localization pattern reflects its role in intraflagellar transport.

To visualize WDR19 localization, researchers can use immunofluorescence techniques with anti-WDR19 antibodies. Typical protocols include:

• Fixation of cells (often with 4% paraformaldehyde)

• Permeabilization with detergents

• Overnight incubation at 4°C with primary antibodies (such as rabbit polyclonal anti-WDR19)

• Washing with phosphate buffer saline (PBS)

• Incubation with appropriate secondary antibodies (e.g., anti-rabbit-Alexa Fluor-594)

• Imaging with confocal microscopy for optimal visualization of subcellular localization

How do mutations in WDR19 affect protein localization and function in ciliopathies?

Mutations in WDR19 can significantly alter protein localization and function, leading to ciliopathic phenotypes. In a study of a homozygous WDR19 c.A3811G (p.K1271E) missense mutation in a patient with asthenoteratospermia, immunofluorescence staining revealed complete absence of WDR19 from the sperm where it would normally be expressed . This mutation also affected the localization of other IFT proteins - IFT140 immunostaining, normally localized in the middle of sperm head and flagellum, was abnormally accumulated in the top of the sperm head and neck in WDR19-mutated specimens . Similarly, IFT88 was abnormally located in the sperm neck rather than in the sperm manchette and flagellum .

The consequences of these mislocalization events were severe ultrastructural defects. SEM analysis showed primarily short and coiled flagella, while TEM analysis revealed significant disruption of the typical "9+2" microtubule arrangement, with most sperm showing complete absence of microtubule structures or a 9+0 arrangement (lacking the central pair of microtubules) . These findings demonstrate how WDR19 mutations can disrupt not only its own localization but also that of interacting partners, leading to profound structural and functional defects.

What are the optimal experimental designs for studying WDR19 interactions with other IFT complex components?

When designing experiments to study WDR19's interactions with other IFT complex components, researchers should consider several approaches:

• Co-immunoprecipitation (Co-IP): Using anti-WDR19 antibodies for immunoprecipitation, followed by Western blot analysis for potential interacting partners. For example, WDR19 can be immunoprecipitated from cell lysates using antibodies like ab270970 at 1/30 dilution (2μg in 0.35mg lysates), followed by Western blot confirmation with the same antibody at 1/1000 dilution .

• Immunofluorescence co-localization: Double staining for WDR19 and potential interacting partners (such as IFT140, IFT88) can reveal spatial relationships. This approach was effectively used to demonstrate altered localization of IFT140 and IFT88 in WDR19-mutated sperm .

• Proximity ligation assays: These can be used to visualize protein-protein interactions in situ with higher specificity than simple co-localization.

• Functional studies with genetic manipulation: Studying how knockout or mutation of WDR19 affects the localization and function of other IFT complex components can provide insights into their interdependence.

• Expression of truncated or domain-specific mutants to map interaction regions.

How can researchers differentiate between primary effects of WDR19 dysfunction and secondary consequences?

Differentiating between primary effects of WDR19 dysfunction and secondary consequences requires careful experimental design:

• Temporal studies: Examining the sequence of events following WDR19 inactivation can help determine which effects occur first (likely primary) versus those that develop later (likely secondary).

• Rescue experiments: Reintroducing wild-type WDR19 into deficient cells and observing which phenotypes are rescued immediately versus those requiring longer-term expression can distinguish primary from secondary effects.

• Domain-specific mutations: Creating variants that disrupt specific interactions rather than eliminating the entire protein can help pinpoint primary functions.

• Comparative studies across different mutational models: Different mutations in WDR19 may affect different functions, helping to dissect its various roles.

• Analysis of direct binding partners versus downstream effectors: Direct interactors like IFT140 and IFT88 are more likely to show primary effects of WDR19 dysfunction, while more distant pathway components may exhibit secondary consequences.

What are the optimal conditions for Western blot detection of WDR19?

For optimal Western blot detection of WDR19, researchers should consider the following parameters:

• Gel selection: Use 5% SDS PAGE gels due to the large size of WDR19 (approximately 145-151 kDa) .

• Sample preparation:

  • For human samples: HeLa whole cell lysate at 30 μg has been successfully used

  • For mouse samples: Mouse brain whole cell lysate at 50 μg provides good results

• Antibody dilution: A 1/1000 dilution has been effective for antibodies such as ab105044 and ab270970 .

• Detection system: Use appropriate secondary antibodies and detection reagents compatible with the primary antibody host species. For immunoprecipitation Western blots, specialized secondary antibodies like VeriBlot for IP Detection Reagent may be used at 1/5000 dilution to minimize interference from the immunoprecipitating antibody .

• Expected band size: Anticipate bands at approximately 151 kDa for human samples and 145 kDa for mouse samples .

• Controls: Include positive control lysates from tissues known to express WDR19, such as brain tissue.

How can immunofluorescence protocols be optimized for WDR19 detection in different tissue types?

Optimizing immunofluorescence protocols for WDR19 detection across different tissue types requires attention to several factors:

• Fixation method: Different tissues may require different fixation approaches. For sperm samples, protocols using 4% paraformaldehyde have been successful .

• Primary antibody selection and dilution: Different antibodies may perform optimally in different tissue contexts. For sperm immunofluorescence, rabbit polyclonal anti-WDR19 (13647-1-AP, proteintech) has been effectively used at 1:100 dilution .

• Blocking conditions: Optimize blocking to reduce background signal, which may vary by tissue type.

• Secondary antibody selection: Match appropriately to the primary antibody host species, and consider using highly cross-adsorbed secondary antibodies to minimize non-specific binding. Anti-rabbit-Alexa Fluor-594 has been successfully used for WDR19 detection .

• Co-staining strategies: Consider using ciliary markers like acetylated alpha-tubulin (antibody 5335S, CST, 1:500) to confirm proper localization to ciliary structures .

• Imaging parameters: Use confocal microscopy (such as Zeiss LSM 710) for optimal visualization of subcellular localization patterns .

What validation methods should be employed to confirm WDR19 antibody specificity?

To confirm WDR19 antibody specificity, researchers should employ multiple validation approaches:

• Genetic validation: Testing the antibody in WDR19 knockout or knockdown models should show reduced or absent signal compared to wild-type samples. In published research, the absence of WDR19 staining in sperm from patients with WDR19 mutations provided strong validation of antibody specificity .

• Peptide competition assays: Pre-incubation of the antibody with purified WDR19 recombinant protein antigen should block specific staining. Products like NBP1-84033PEP (WDR19 Recombinant Protein Antigen) are specifically designed for antibody competition assays .

• Multiple antibody comparison: Testing multiple antibodies targeting different epitopes of WDR19 should yield similar staining patterns if they are specific.

• RNA-protein correlation: Correlating protein detection with mRNA levels can provide additional validation. For example, qPCR showing decreased WDR19 mRNA levels in samples with reduced antibody staining strengthens specificity claims .

• Predicted vs. observed molecular weight: Confirming that Western blot bands appear at the expected molecular weight (145-151 kDa for WDR19) supports antibody specificity .

How can researchers address weak or absent WDR19 signals in Western blot applications?

When encountering weak or absent WDR19 signals in Western blots, researchers can implement several troubleshooting strategies:

• Sample loading: Increase the amount of protein loaded (up to 50 μg for mouse brain samples has been successful) .

• Enrichment strategies: Consider subcellular fractionation to concentrate ciliary proteins.

• Antibody concentration: Test higher concentrations of primary antibody while monitoring background levels.

• Extraction conditions: Optimize lysis buffers to efficiently extract membrane-associated proteins like WDR19.

• Transfer conditions: For large proteins like WDR19 (145-151 kDa), extended transfer times or specialized transfer methods for high molecular weight proteins may be necessary.

• Detection system sensitivity: Use enhanced chemiluminescence reagents or switch to more sensitive fluorescent secondary antibodies.

• Fresh samples: Ensure protein samples are properly stored and free from degradation.

• Alternative antibodies: If one antibody fails to detect WDR19, try alternative antibodies that target different epitopes.

What strategies can address non-specific binding issues in immunofluorescence experiments?

To address non-specific binding in immunofluorescence experiments with WDR19 antibodies:

• Optimization of blocking: Test different blocking agents (BSA, normal serum, commercial blockers) and blocking durations.

• Antibody titration: Determine the minimum concentration needed for specific signal without excess that could contribute to non-specific binding.

• Secondary antibody controls: Always include controls with secondary antibody only to identify potential direct secondary antibody binding.

• Washing optimization: Increase the number and duration of washing steps with PBS to remove weakly bound antibody.

• Pre-adsorption: Consider pre-adsorbing the primary antibody with tissue lysates from WDR19-negative tissues.

• Alternative fixation methods: Different fixation protocols may affect epitope accessibility and non-specific binding.

• Autofluorescence reduction: Implement steps to reduce tissue autofluorescence, which can be mistaken for specific staining.

How should researchers interpret conflicting data between different WDR19 antibodies?

When faced with conflicting data between different WDR19 antibodies, researchers should consider:

• Epitope differences: Different antibodies may target different regions of WDR19. Map the epitopes of each antibody and consider whether post-translational modifications, protein interactions, or conformational changes might affect accessibility of specific epitopes.

• Antibody validation status: Evaluate the validation evidence for each antibody. More extensively validated antibodies (like those with knockout controls) should generally be given greater weight.

• Application-specific performance: Some antibodies may perform well in Western blot but poorly in immunofluorescence, or vice versa.

• Tissue/cell type differences: Conflicting results might reflect genuine biological differences in WDR19 expression or localization across different tissues or cell types.

• Experimental conditions: Differences in fixation, permeabilization, or other protocol elements might affect antibody performance.

• Independent validation methods: Use non-antibody-based approaches (such as GFP-tagged WDR19 expression) to resolve conflicts.

• Literature comparison: Compare your results with published findings using the same antibodies to identify potential technical issues.

How can WDR19 antibodies be utilized to study ciliopathies and fertility disorders?

WDR19 antibodies serve as valuable tools for investigating ciliopathies and fertility disorders:

• Diagnostic applications: WDR19 antibodies can be used to screen patient samples for abnormal localization or expression of WDR19, potentially aiding in the diagnosis of certain ciliopathies. In a study of asthenoteratospermia, immunofluorescence with WDR19 antibodies revealed complete absence of the protein from sperm flagella in affected patients .

• Phenotype-genotype correlations: By examining WDR19 expression and localization in patients with known WDR19 mutations, researchers can correlate specific mutations with their effects on protein function. For example, the homozygous WDR19 c.A3811G (p.K1271E) mutation resulted in complete loss of detectable WDR19 in sperm flagella .

• Structure-function studies: Comparing the effects of different WDR19 mutations on flagellar/ciliary ultrastructure can provide insights into which domains are critical for specific functions. TEM analysis of sperm from a patient with the p.K1271E mutation showed severe ultrastructural defects, including complete disorganization of the "9+2" microtubule arrangement .

• Therapeutic monitoring: In potential future gene therapy approaches, WDR19 antibodies could monitor restoration of proper protein expression and localization.

• Reproductive technologies assessment: Understanding the impact of WDR19 mutations on fertility can guide reproductive technology approaches. For instance, despite severe flagellar abnormalities, ICSI (intracytoplasmic sperm injection) with sperm from a WDR19-mutated patient resulted in successful fertilization and pregnancy .

What are the considerations for using WDR19 antibodies in high-resolution imaging techniques?

When using WDR19 antibodies for high-resolution imaging techniques, researchers should consider:

• Antibody penetration: For super-resolution microscopy, complete antibody penetration becomes more critical. Optimize permeabilization conditions while maintaining structural integrity.

• Signal-to-noise ratio: Higher resolution techniques amplify both signal and noise, making antibody specificity and background reduction even more crucial.

• Fixation effects on epitope preservation: Different fixation methods may better preserve the three-dimensional structure of cilia/flagella for high-resolution imaging.

• Co-localization precision: For co-localization studies with other IFT components, ensure both primary antibodies (e.g., WDR19 and IFT140) are highly specific to avoid false-positive co-localization signals.

• Appropriate controls: Include negative controls (WDR19-deficient samples if available) and positive controls (tissues with known WDR19 expression patterns).

• Fluorophore selection: Choose bright, photostable fluorophores compatible with the specific high-resolution technique being used.

• Sample mounting: Use mounting media that minimize spherical aberrations and preserve fluorescence.

How can quantitative analysis of WDR19 expression be standardized across research studies?

Standardizing quantitative analysis of WDR19 expression across research studies requires:

• Standardized reference samples: Include common reference samples or standards across studies to allow for data normalization.

• Consistent antibody usage: When possible, use the same validated antibodies across studies. Document antibody catalog numbers, lots, and dilutions used.

• Digital image acquisition parameters: Standardize and report microscope settings, exposure times, and detector gain settings.

• Quantification methodology: Clearly define methods for quantifying immunofluorescence intensity or Western blot band density, including software used and processing algorithms.

• Normalization approach: Standardize the loading controls or housekeeping proteins used for Western blot normalization.

• Blinding procedures: Implement blinded analysis to prevent bias in quantification.

• Statistical methods: Use consistent statistical approaches and reporting standards for analyzing differences in WDR19 expression.

• Metadata reporting: Document experimental conditions comprehensively to allow for meaningful cross-study comparisons.